Understanding the interaction of upper respiratory tract infection with respiratory syncytial virus and Streptococcus pneumoniae using a human challenge model: a multicenter, randomized controlled study protocol.
Saved in:
| Title: | Understanding the interaction of upper respiratory tract infection with respiratory syncytial virus and Streptococcus pneumoniae using a human challenge model: a multicenter, randomized controlled study protocol. |
|---|---|
| Authors: | Brito-Mutunayagam S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Hamilton DO; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Mitsi E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Solórzano C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Li G; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Rocha De Macedo B; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Elterish F; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Liu X; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Tanha K; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., White R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Hyder-Wright A; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Patel B; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Urban BC; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Whelan C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Trari Belhadef H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Thompson A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Lahuerta M; Pfizer Vaccines, Pfizer Inc, New York, New York, United States of America., Kanevsky I; Pfizer Vaccines, Pfizer Inc, New York, New York, United States of America., Swanson K; Pfizer Vaccines, Pfizer Inc, New York, New York, United States of America., Aliabadi N; Pfizer Vaccines, Pfizer Inc, New York, New York, United States of America., Catusse J; Pfizer Vaccines, Pfizer Inc, New York, New York, United States of America., Theilacker C; Pfizer Vaccines, Pfizer Inc, New York, New York, United States of America., Gessner BD; Pfizer Vaccines, Pfizer Inc, New York, New York, United States of America., Mazur NI; Department of Pediatric Infectious Diseases and Immunology, University Medical Centre Utrecht, Utrecht, Netherlands., Chiu C; Department of Infectious Disease, Imperial College London, London, United Kingdom., Collins AM; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.; University Hospital Liverpool Group, Liverpool, United Kingdom., Morton B; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Ferreira DM; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom. |
| Source: | PloS one [PLoS One] 2025 Jul 01; Vol. 20 (7), pp. e0325149. Date of Electronic Publication: 2025 Jul 01 (Print Publication: 2025). |
| Publication Type: | Clinical Trial Protocol; Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0325149 |
